We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Primate Form of HIV Kills Chimps Early

New study provides insight into how as AIDS-like disease develops in wild African chimpanzees.
News

SemBioSys Awarded Key U.S. Patent for the Production of Insulin in Plants

Patent provides claims directed to a method for the commercial production of insulin in plant seeds.
News

BioInvent Signs Licensing Agreement with Mitsubishi Tanabe Pharma Corporation

Under the terms of the agreement, Mitsubishi Tanabe will be granted access to BioInvent’s discovery and development technology platform.
News

Bruker Announces new Mass Spectrometry Joint Venture in India

New Bruker LabMate joint venture company established to further enhance customer support for life-science mass spectrometry in Indian market.
News

Debiopharm and MSM Protein Technologies Sign Agreement for Research and Development of Debio 0929

Companies enter an exclusive partnership to select antibodies against the GPCR.
News

DxS Collaborates with AstraZeneca to Provide a Companion Diagnostic for IRESSA™

DxS’ TheraScreen®: EGFR29 Mutation Kit will be used to test the mutation status of a patient’s EGFR oncogene for treatment with IRESSA™.
News

Fox Chase Researchers Uncover One Force behind the MYC Oncogene in Many Cancers

Researchers discover how embryonic gene, DLX5, may cause cancers in adults.
News

Gene Developed through Conventional Breeding to Improve Cowpea Aphid Resistance

Researchers are testing several new lines of cowpeas with genes that are aphid-resistant and less susceptible to disease.
News

Genes Key to Staph Disease Severity, Drug Resistance Found Hitchhiking Together

Scientists have also found the gene for the toxin traveling with a genetic component of Staphylococcus that controls resistance to antibiotics.
News

Higher Drug Doses Needed to Defeat Tuberculosis, UT Southwestern Researchers Report

The typical dose of a medication considered pivotal in treating tuberculosis effectively is much too low to account for modern-day physiques, researchers say.
Advertisement